Isaac Angres
14Patents
3h-index
18Co-inventors
57Inventor score
Filing activity: Oct 17, 1977 → Apr 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6001828A | Use of tumor factor inhibitors together with antiviral agents and therapeutic compositions thereof against HIV infection | Human Necessities | 8 | Expired |
| US5179097A | Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids | Chemistry; Metallurgy | 5 | Expired |
| US6890941B1 | Compositions containing HMG Co-A reductase inhibitors and policosanol | Human Necessities | 5 | Expired |
| US4158649A | Polymeric membranes which contain polyphenylquinoxalines and which are useful as battery separators | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8309024B2 | Methods and systems for non-destructive determination of fluorination of carbon powders | Physics | 2 | Active |
| US9890988B2 | High temperature resistant shipping container | Emerging Cross-Sectional Technologies | 2 | Active |
| US4172088A | Bis(2-fluoro-2,2-dinitroethyl)thionocarbonate and a method of preparation | Chemistry; Metallurgy | 1 | Expired |
| US9877982B2 | Immunoassay of S-adenosylmethionine using analogs thereof and personalized therapeutics | Physics | 1 | Active |
| US4199532A | Method for the production of hexanitrostilbene | Chemistry; Metallurgy | 1 | Expired |
| US9885723B2 | Immunoassays of S-adenosylmethionine and methylation index in personalized medicine and health evaluation | Emerging Cross-Sectional Technologies | 0 | Active |
| US9958447B2 | Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation | Physics | 0 | Active |
| US10663470B2 | Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation | Physics | 0 | Active |
| US5157151A | Salts of 1-adamantamine and formulations thereof | Chemistry; Metallurgy | 0 | Expired |
| US10656159B2 | Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.